Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Drug Pricing Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax Antimicrobial Resistance/HR 3932 COVID Relief Package/Appropriations PDUFA
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2022 · second_quarter · 2A
Medicare Part D support for access to treatments for obesity Coverage Gap Rebate Reform Out-of-Pocket Costs Government Negotiation in Medicare
TRIPS Waiver General IP Issues Bayh-Dole March-In Rights
Source: Senate LDA
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Drug Pricing Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax Antimicrobial Resistance/HR 3932 COVID Relief Package/Appropriations PDUFA
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Drug Pricing Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax Antimicrobial Resistance/HR 3932 COVID Relief Package/Appropriations PDUFA
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Drug Pricing Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax Antimicrobial Resistance/HR 3932 COVID Relief Package/Appropriations PDUFA
Drug Pricing Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax Antimicrobial Resistance/HR 3932 COVID Relief Package/Appropriations PDUFA
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Drug Pricing Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax Antimicrobial Resistance/HR 3932 COVID Relief Package/Appropriations PDUFA
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Protecting Lands Against Narcotics Trafficking Act of 2013
Client: PFIZER INC. · Firm: PFIZER INC.
Deferral Excess Returns/Base Erosion Comprehensive Tax Reform Transition Rules for Comprehensive ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency
Protecting Lands Against Narcotics Trafficking Act of 2013
Client: PFIZER INC. · Firm: PFIZER INC.
Deferral Excess Returns/Base Erosion Comprehensive Tax Reform Transition Rules for Comprehensive ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency
Health Care Reform FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer ProgramDeficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Health Care Reform FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer ProgramDeficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Health Care Reform FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer ProgramDeficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Health Care Reform FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer ProgramDeficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureaucrats Elimination Act, 2011
Health Care Reform Prescription Drug User Fee Act (PDUFA) Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 3817, Food and Drug Administration Safety and Innovation Act
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureacrats Elimination Act, 2011
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureacrats Elimination Act, 2011
Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax Reform Territorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 2495, Tax Equity and Middle Class Fairness Act (excess returns) H.R. 4348, Authorized Surface Transportation Funding Through September 2014 and Extend Student Loan Rate for the Year S. 1813, Moving Ahead for Progress in the 21st Century Act "Highway Bill"
To amend the Internal Revenue Code of 1986 to make permanent the look-through treatment of payments between related controlled foreign corporations.
Client: PFIZER INC. · Firm: PFIZER INC.
Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax Reform Territorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 2495, Tax Equity and Middle Class Fairness Act (excess returns) H.R. 4348, Authorized Surface Transportation Funding Through September 2014 and Extend Student Loan Rate for the Year S. 1813, Moving Ahead for Progress in the 21st Century Act "Highway Bill"
Health Care Reform Prescription Drug User Fee Act (PDUFA) Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 3817, Food and Drug Administration Safety and Innovation Act
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureacrats Elimination Act, 2011
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureaucrats Elimination Act, 2011
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureacrats Elimination Act, 2011
Health Care Reform Prescription Drug User Fee Act (PDUFA) Antibiotic Incentives FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Health Care Reform Prescription Drug User Fee Act (PDUFA) Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 3817, Food and Drug Administration Safety and Innovation Act
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders FDA Funding Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Vaccines (317 Program appropriations, Immunization Improvements Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 1599, FY 2012 Labor HHS Appropriations Bill S. 668, Health Care Bureacrats Elimination Act, 2011
Medicare Prescription Drug Benefit Medicare Rebates Medicare Coverage Medicare Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation Debt Ceiling and Part D H.R. 452, Medicare Decision Accountability Act, 2011 S. 1206, Medicare Drug savings Act
Medicare Prescription Drug Benefit Medicare Rebates/Medicare Part D Medicare Coverage Debt Ceiling and Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation H.R. 452, Medicare Decision Accountability Act, 2011 S. 1206, Medicare Drug Savings Act
Medicare Prescription Drug Benefit Medicare Rebates Medicare Coverage Medicare Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation Debt Ceiling and Part D H.R. 452, Medicare Decision Accountability Act, 2011 S. 1206, Medicare Drug savings Act
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders FDA Funding Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Vaccines (317 Program appropriations, Immunization Improvements Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 1599, FY 2012 Labor HHS Appropriations Bill S. 668, Health Care Bureacrats Elimination Act, 2011
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
Medicare Prescription Drug Benefit Medicare Rebates/Medicare Part D Medicare Coverage Debt Ceiling and Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation H.R. 452, Medicare Decision Accountability Act, 2011 S. 1206, Medicare Drug Savings Act
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders FDA Funding Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Vaccines (317 Program appropriations, Immunization Improvements Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 1599, FY 2012 Labor HHS Appropriations Bill S. 668, Health Care Bureacrats Elimination Act, 2011
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance Senate Labor - HHS Appropriations bill, with regard to funding of the 317 Program H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance Senate Labor - HHS Appropriations bill, with regard to funding of the 317 Program H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders FDA Funding Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Vaccines (317 Program appropriations, Immunization Improvements Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 1599, FY 2012 Labor HHS Appropriations Bill S. 668, Health Care Bureacrats Elimination Act, 2011
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders FDA Funding Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Vaccines (317 Program appropriations, Immunization Improvements Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 1599, FY 2012 Labor HHS Appropriations Bill S. 668, Health Care Bureacrats Elimination Act, 2011
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance Senate Labor - HHS Appropriations bill, with regard to funding of the 317 Program H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders FDA Funding Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Vaccines (317 Program appropriations, Immunization Improvements Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 1599, FY 2012 Labor HHS Appropriations Bill S. 668, Health Care Bureacrats Elimination Act, 2011
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance Senate Labor - HHS Appropriations bill, with regard to funding of the 317 Program H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance Senate Labor - HHS Appropriations bill, with regard to funding of the 317 Program H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance Senate Labor - HHS Appropriations bill, with regard to funding of the 317 Program H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: PFIZER INC. · Firm: PFIZER INC.
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act
Setting forth the congressional budget for the United States Government for fiscal year 2010 and including the appropriate budgetary levels for fiscal years 2009 and 2011 through 2014.
Client: PFIZER INC. · Firm: PFIZER INC.
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
Importation H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09 H.R. 573 - Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Importation H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09 H.R. 573 - Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER INC. · Firm: PFIZER INC.
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER INC. · Firm: PFIZER INC.
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER INC. · Firm: PFIZER INC.
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Promoting Innovation and Access to Life-Saving Medicine Act
Client: PFIZER INC. · Firm: PFIZER INC.
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: PFIZER INC. · Firm: PFIZER INC.
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: PFIZER INC. · Firm: PFIZER INC.
Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: PFIZER INC. · Firm: PFIZER INC.
Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
Preservation of Antibiotics for Medical Treatment Act of 2009
Client: PFIZER INC. · Firm: PFIZER INC.
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act
Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: PFIZER INC. · Firm: PFIZER INC.
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: PFIZER INC. · Firm: PFIZER INC.
Importation H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09 H.R. 573 - Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: PFIZER INC. · Firm: PFIZER INC.
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: PFIZER INC. · Firm: PFIZER INC.
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Client: PFIZER INC. · Firm: PFIZER INC.
Importation H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09 H.R. 573 - Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09
Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
Food and Drug Administration Globalization Act of 2009
Client: PFIZER INC. · Firm: PFIZER INC.
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2022 · first_quarter · 1A
TRIPS Waiver General IP Issues Bayh-Dole March-In Rights
Medicare Part D Coverage Gap Rebate Reform Out-of-Pocket Costs Government Negotiation in Medicare
Drug Pricing Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax Antimicrobial Resistance/HR 3932 COVID Relief Package/Appropriations PDUFA
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2022 · fourth_quarter · Q4
Comprehensive Corporate Tax Reform International Tax Reform OECD Profit Allocation U.S. Manufacturing Credits Build Back Better Act Minimum Tax
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Medicare Part D support for access to treatments for obesity Coverage Gap Rebate Reform Out-of-Pocket Costs Government Negotiation in Medicare
NAFTA/USMCA Foreign Market Access issues (including IPR) International Supply Chain/Buy America - harmonize international drug manufacturing standards. Global Access to Medicines
TRIPS Waiver General IP Issues Bayh-Dole March-In Rights
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2022 · third_quarter · Q3
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
TRIPS Waiver General IP Issues Bayh-Dole March-In Rights
Medicare Part D support for access to treatments for obesity Coverage Gap Rebate Reform Out-of-Pocket Costs Government Negotiation in Medicare
Comprehensive Corporate Tax Reform International Tax Reform OECD Profit Allocation U.S. Manufacturing Credits Build Back Better Act Minimum Tax
NAFTA/USMCA Foreign Market Access issues (including IPR) International Supply Chain/Buy America - harmonize international drug manufacturing standards. Global Access to Medicines
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2022 · second_quarter · 2A
TRIPS Waiver General IP Issues Bayh-Dole March-In Rights
Medicare Part D support for access to treatments for obesity Coverage Gap Rebate Reform Out-of-Pocket Costs Government Negotiation in Medicare
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2022 · first_quarter · 1A
TRIPS Waiver General IP Issues Bayh-Dole March-In Rights
Medicare Part D Coverage Gap Rebate Reform Out-of-Pocket Costs Government Negotiation in Medicare
Drug Pricing Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax Antimicrobial Resistance/HR 3932 COVID Relief Package/Appropriations PDUFA
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2022 · second_quarter · Q2
TRIPS Waiver General IP Issues Bayh-Dole March-In Rights
Drug Pricing Support of Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax- S.3087 Antimicrobial Resistance/HR 3932/PASTEUR Act COVID Relief Package/Appropriations PDUFA
Medicare Part D support for access to treatments for obesity Coverage Gap Rebate Reform Out-of-Pocket Costs Government Negotiation in Medicare
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2022 · first_quarter · Q1
TRIPS Waiver General IP Issues Bayh-Dole March-In Rights
Drug Pricing Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure/HR 3656 Excise Tax Antimicrobial Resistance/HR 3932 COVID Relief Package/Appropriations PDUFA
Medicare Part D Coverage Gap Rebate Reform Out-of-Pocket Costs Government Negotiation in Medicare
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2021 · first_quarter · 1A
Drug Pricing Biosimilars Drug Shortages Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure Drug Importation
TRIPS Waiver
Medicare Part D Coverage Gap Rebate Reform Out-of-Pocket Costs Price Transparency International Reference Pricing/Most Favored Nations
2021 · fourth_quarter · Q4
Comprehensive Corporate Tax Reform International Tax Reform OECD Profit Allocation Manufacturing Credits
NAFTA/USMCA Foreign Market Access issues (including IPR) International Supply Chain/Buy America
Medicare Part D Coverage Gap Rebate Reform Out-of-Pocket Costs International Reference Pricing/Most Favored Nations
2021 · third_quarter · Q3
Medicare Part D Coverage Gap Rebate Reform Out-of-Pocket Costs International Reference Pricing/Most Favored Nations
Drug Pricing Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure Antimicrobial Resistance
TRIPS Waiver
2021 · second_quarter · Q2
Drug Pricing Biosimilars Drug Shortages Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure Antimicrobial Resistance
Medicare Part D Coverage Gap Rebate Reform Out-of-Pocket Costs International Reference Pricing/Most Favored Nations
Comprehensive Corporate Tax Reform International Tax Reform OECD Profit Allocation Manufacturing Credits
2021 · first_quarter · Q1
Drug Pricing Biosimilars Drug Shortages Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure Drug Importation
Medicare Part D Coverage Gap Rebate Reform Out-of-Pocket Costs Price Transparency International Reference Pricing/Most Favored Nations
TRIPS Waiver
2020 · fourth_quarter · Q4
Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Price Transparency International Reference Pricing/Most Favored Nations
Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Rebate Reform Vaccine Infrastructure Drug Importation
Comprehensive Corporate Tax Reform International Tax Reform OECD Profit Allocation Manufacturing Credits
2020 · third_quarter · Q3
Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements Price Transparency International Reference Pricing/Most Favored Nations
Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform Vaccine Infrastructure Drug Importation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2020 · second_quarter · Q2
Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform Vaccine Infrastructure
Comprehensive Corporate Tax Reform International Tax Reform OECD Profit Allocation Manufacturing Credits
Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements Price Transparency
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2020 · first_quarter · Q1
Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements Price Transparency
U.S.- Japan Trade Negotiations China Trade Negotiations Foreign Market Access Issues NAFTA/USMCA International Supply Chain/Buy America U.S.- U.K. Trade Negotiations U.S. - Kenya FTA
Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2019 · fourth_quarter · 4A
U.S.- Japan Trade Negotiations China Trade Negotiations NAFTA/USMCA Foreign Market Access Issues
Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements Price Transparency
Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2019 · fourth_quarter · Q4
U.S.- Japan Trade Negotiations China Trade Negotiations NAFTA/USMCA Foreign Market Access Issues
Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements Price Transparency
Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2019 · third_quarter · Q3
Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform
U.S.- Japan Trade Negotiations China Trade Negotiations NAFTA/USMCA
Creates Act
2019 · second_quarter · Q2
Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform
Creates Act
U.S.- Japan Trade Negotiations China Trade Negotiations APEC OECD NAFTA/USMCA Brazil Trade Chile IP/Trade Argentina PAC-DBIA India Trade Turkey Trade
2019 · first_quarter · 1A
Creates Act
Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform
Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2019 · first_quarter · Q1
Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements
Creates Act
Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2018 · fourth_quarter · 4A
Comprehensive Corporate Tax Reform Tax Cuts and Jobs Act of 2017 (TCJA)
Drug Pricing Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA
Medicare Part D Coverage Gap
2018 · third_quarter · 3A
2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018
Creates Act Transferable exclusivity
Prescription Drug Abuse
2018 · fourth_quarter · Q4
Comprehensive Corporate Tax Reform Tax Cuts and Jobs Act of 2017 (TCJA)
Creates Act Transferable exclusivity
Drug Pricing Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA
2018 · third_quarter · Q3
Prescription Drug Abuse
Comprehensive Corporate Tax Reform Tax Cuts and Jobs Act of 2017 (TCJA)
Drug Pricing Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA
2018 · second_quarter · 2A
Medicare Part D Coverage Gap Biosimilar pass-through
Comprehensive Corporate Tax Reform
Creates Act Patent Settlements Transferable exclusivity
2018 · second_quarter · 2A
Comprehensive Corporate Tax Reform
Creates Act Patent Settlements Transferable exclusivity
Drug Pricing Biosimilars Reimbursement Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA
2018 · second_quarter · Q2
Medicare Part D Coverage Gap Biosimilar pass-through
2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018 Omnibus Appropriations Act of 2018
Comprehensive Corporate Tax Reform
2018 · first_quarter · Q1
Medicare Part D Coverage Gap Biosimilar pass-through
Prescription Drug Abuse
Drug Pricing Biosimilars Reimbursement Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease
2018 · first_quarter · RA
Healthcare and access issues/IP Protection/Trade
Healthcare and access issues/IP Protection/Trade
Healthcare and access issues/IP Protection/Trade
2017 · third_quarter · 3A
Drug Pricing User Fees Biosimilars Reimbursement Antibiotic Resistance Drug Shortages Reimbursement for products treating Sickle Cell Disease
Medicare Rebates/Medicare Part D/C Medicare Part B CMMI Demo Non-Interference Re-Importation
Comprehensive Tax Reform Territorial Systems Deferral Border Adjustable Tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2017 · fourth_quarter · Q4
Comprehensive Tax Reform Territorial Systems Border Adjustability Tax
2018 FDA & Labor/HHS Appropriation Bills
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill Trans-Atlantic trade & Investment Partnership Canada IP/Trade Issues South Africa IP Issues China IP Indonesia IP Thailand IP Korea Pricing Issues United Nations Health Panel G7/G20 APEC OECD Australia Market - Size Damages WTO "Zero for Zero" Pharmaceutical Agreement NAFTA
2017 · third_quarter · Q3
Medicare Rebates/Medicare Part D/C Medicare Part B CMMI Demo Non-Interference Re-Importation
Comprehensive Tax Reform Territorial Systems Deferral Border Adjustable Tax
Drug Pricing User Fees Biosimilars Reimbursement Antibiotic Resistance Drug Shortages Reimbursement for products treating Sickle Cell Disease
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2017 · first_quarter · 1A
Prescription Drug Abuse
Medicare Rebates/Medicare Part D Medicare Part B CMMI Demo Non-Interference Re-Importation
Drug Pricing User Fees Biosimilars Reimbursement
2017 · second_quarter · Q2
Medicare Rebates/Medicare Part D Medicare Part B CMMI Demo Non-Interference Re-Importation Part A Reimbursement
Comprehensive Tax Reform Territorial Systems Deferral Border Adjustable Tax
Prescription Drug Abuse
2017 · first_quarter · Q1
Comprehensive Tax Reform Territorial Systems Deferral Border Adjustable Tax
Prescription Drug Abuse
Drug Pricing User Fees Biosimilars Reimbursement
2016 · fourth_quarter · 4A
Medicare Rebates/Medicare Part D Non-Interference Medicare Part B Reimbursement Medicare Part B CMMI Demo Re-importation
Omnibus Appropriations Bill 2017 FDA & Labor/HHS Appropriation Bills
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy User Fees
2016 · third_quarter · 3A
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy
Prescription Drug Abuse
Medicare Rebates/Medicare Part D Non-Interference Medicare Part B Reimbursement Medicare Part B CMMI Demo
2016 · second_quarter · 2A
Deferral Comprehensive Tax Reform Territorial Systems Patent Innovation Box Cadillac Tax Inversions Section 385 Proposed Regulations
Omnibus Appropriations Bill LHHA Appropriations 2017 FDA & Labor/HHS Appropriation Bills
Medicare Rebates/Medicare Part D Non-Interference Medicare Part B Reimbursement Medicare Part B CMMI Demo
2016 · fourth_quarter · Q4
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Canada IP/Trade Issues South Africa IP Issues China IP Issues Indonesia IP Issues Thailand IP Issues Korea Pricing Issues Saudia Arabia Pricing Issues United Nations Health Panel Privacy Shield G7/G20 APEC OECD
Prescription Drug Abuse
Medicare Rebates/Medicare Part D Non-Interference Medicare Part B Reimbursement Medicare Part B CMMI Demo Re-importation
2016 · second_quarter · 2A
Medicare Rebates/Medicare Part D Non-Interference Medicare Part B Reimbursement Medicare Part B CMMI Demo
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Canada IP/Trade Issues South Africa IP Issues China IP Saudia Arabia Pricing Issues United Nations Health Panel Thermacare EU Privacy Shield G7/G20 APEC OECD
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy
2016 · third_quarter · Q3
Deferral Comprehensive Tax Reform Territorial Systems Patent Innovation Box Inversions Section 385 Proposed Regulations
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy
Medicare Rebates/Medicare Part D Non-Interference Medicare Part B Reimbursement Medicare Part B CMMI Demo
2016 · second_quarter · Q2
Medicare Rebates/Medicare Part D Non-Interference Medicare Part B Reimbursement Medicare Part B CMMI Demo
Omnibus Appropriations Bill LHHA Appropriations 2017 FDA & Labor/HHS Appropriation Bills
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy
2016 · first_quarter · Q1
Deferral Comprehensive Tax Reform Territorial Systems Patent Innovation Box Cadillac Tax Inversions
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy
Medicare Rebates/Medicare Part D Non-Interference Medicare Part B Reimbursement Medicare Part B Demonstration Proposal Medicare Part B CMMI Demo
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
2015 · fourth_quarter · Q4
Deferral Comprehensive Tax Reform Territorial Systems Tax Extenders Patent Innovation Box Cadillac Tax Inversions
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues China IP Saudia Arabia Pricing Issues WTO Trade Facilitation Agreement (TFA) Trade Adjustment Assistance United Nations Health Panel
Medicare Rebates/Medicare Part D Non-Interference
2015 · third_quarter · 3A
FDA Funding 340B 21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy
Preventing Abuse of Cough Treatment Act
Medicare Rebates/Medicare Part D Non-Interference SGR "Fix" Negotiations IPAB
2015 · second_quarter · 2A
Medicare Rebates/Medicare Part D Non-Interference SGR "Fix" Negotiations IPAB
Deferral Comprehensive Tax Reform Territorial Systems Tax Extenders Patent Innovation Box
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues China IP Algeria Pricing Issues Saudia Arabia Pricing Issues WTO Trade Facilitation Agreement (TFA) Vietnam Distribution Trade Adjustment Assistance
2015 · second_quarter · Q2
Patent Troll Legislation
FDA Funding HHS Appropriations 340B Antibiotics Dormant Therapies FDA Breakthrough Therapies 21st Century Cures Initiative Senate Innovation Project
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues China IP Algeria Pricing Issues Saudia Arabia Pricing Issues WTO Trade Facilitation Agreement (TFA) Vietnam Distribution Trade Adjustment Assistance
2015 · first_quarter · Q1
Medicare Rebates/Medicare Part D Non-Interference SGR "Fix" Negotiations
Preventing Abuse of Cough Treatment Act
Deferral Comprehensive Tax Reform Territorial Systems Tax Extenders Patent Innovation Box
2014 · third_quarter · Q3
Designer Anabolic Steroid Act
Deferral Comprehensive Tax Reform Territorial Systems BudgetBase Erosion and Profit Shifting (BEPS)
Patent Settlements Patent Troll Legislation Preventing Abuse of Cough Treatment Act
2014 · fourth_quarter · Q4
Health Care Reform FDA Appropriations HHS Appropriations Interior Appropriations 340B Antibiotics/Dormant Therapies Domestic Drug Pricing - General FDA Breakthrough Therapies 21st Century Cures Initiative
STOPPAct (Stop the Tampering of Prescription Pills)
Medicare Rebates/Medicare Part D Non- Interference SGR "Fix" Negotiations CMS Medicare Manual Changes
2014 · third_quarter · Q3
Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP)Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues Korea IP/Trade Issues China IP Saudia Arabia IP Turkey Pricing/IP Taiwan Pricing Issues Thailand Pricing Issues Egypt Pricing Issues Algeria Pricing Issues Venezuela Pricing Issues
Deferral Comprehensive Tax Reform Territorial Systems BudgetBase Erosion and Profit Shifting (BEPS)
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference SGR "Fix" Negotiations
2014 · second_quarter · Q2
Certified Importer Program Supply Chain Issues Designer Anabolic Steroid Act
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference SGR "Fix" Negotiations
Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP)Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues Korea IP/Trade Issues China IP Saudia Arabia IP Turkey Pricing/IP
2014 · first_quarter · Q1
Deferral Excess Returns/Base Erosion Comprehensive Tax Reform Transition Rules for Comprehensive ReformTerritorial Systems Patent/Innovation Box Minimum Tax Taxation or Intangible Income Budget Base Erosion and Profit Shifting (BEPS)
Patent Settlements Patent Troll Legislation CMS Rule Preventing Abuse of Cough Treatment Act
Health Care Reform FDA Funding Prescription Drug User Fee Act (PDUFA) Implementation Budget Control Act/Sequester User FeesHHS Appropriations Interior Appropriations
2013 · third_quarter · 3A
Certified Importer Program Supply Chain Issues
Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP)Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues Korea IP/Trade Issues
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
2013 · second_quarter · 2A
Trans Pacific Partnership Negotiations India IP/Trade Issues
Opioid Abuse Prescription Drug Abuse
Patent Settlements Patent Reform Patent Troll Legislation
2013 · first_quarter · 1A
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
Health Care Reform FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer ProgramDeficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Opioid Abuse Prescription Drug Abuse
2013 · third_quarter · RA
Health care implementation Patent protection Consumer health issues
Health care implementation Patent protection Consumer health issues
Health care implementation Patent protection Consumer health issues
2013 · fourth_quarter · 4A
Deferral Excess Returns/Base Erosion Comprehensive Tax Reform Transition Rules for Comprehensive ReformTerritorial Systems Patent/Innovation Box Minimum Tax Taxation or Intangible Income Budget
Health Care Reform FDA Funding Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Prescription Drug User Fee Act (PDUFA) ImplementationSequester of User Fee
Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP)Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues Korea IP/Trade Issues China IP Saudia Arabia IP Thailand Pricing Taiwan Pricing
2013 · third_quarter · 3A
Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP)Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues Korea IP/Trade Issues
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
Opioid Abuse Prescription Drug Abuse
2013 · second_quarter · 2A
Opioid Abuse Prescription Drug Abuse
Deferral Excess Returns/Base Erosion Comprehensive Tax Reform Transition Rules for Comprehensive ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency
Health Care Reform FDA Funding Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act)Prescription Drug User Fee Act (PDUFA) Implementation Sequester of User Fee Vaccines
2013 · first_quarter · 1A
Health Care Reform FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer ProgramDeficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Trans Pacific Partnership Negotiations India Trade issues
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
2013 · first_quarter · Q1
Certified Importer Program Supply Chain Issues
Opioid Abuse Prescription Drug Abuse
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
2013 · first_quarter · Q1
Certified Importer Program Supply Chain Issues
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
Opioid Abuse Prescription Drug Abuse
2012 · fourth_quarter · Q4
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation
Health Care Reform Prescription Drug User Fee Act (PDUFA) Antibiotic Incentives FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Opioid Abuse Prescription Drug Abuse
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
2012 · third_quarter · Q3
Health Care Reform Prescription Drug User Fee Act (PDUFA) Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 3817, Food and Drug Administration Safety and Innovation Act
Counterfeit Pharmaceuticals Patent Settlements
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation
2012 · second_quarter · Q2
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureaucrats Elimination Act, 2011
2012 · first_quarter · 1A
Opioid Abuse Priscription Drug Abuse
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureacrats Elimination Act, 2011
2012 · first_quarter · Q1
Opioid Abuse Priscription Drug Abuse
Counterfeit Pharmaceuticals Patent Settlements Stop Online Piracy Act
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives FDA Funding Antimicrobial Resistance Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) House and Senate FY 2013 Labor HHS Appropriations H.R. 2182, Generating Antibiotic Incentives Now Act of 2011 H.R. 452, Medicare Decisions Accountability Act S. 1734, Generating Antibiotic Incentives Now Act of 2011 S. 668, Health Care Bureacrats Elimination Act, 2011
2011 · fourth_quarter · 4A
Medicare Rebates/Medicare Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders FDA Funding Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Vaccines (317 Program appropriations, Immunization Improvements Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 1599, FY 2012 Labor HHS Appropriations Bill S. 668, Health Care Bureacrats Elimination Act, 2011
2011 · third_quarter · 3A
Medicare Prescription Drug Benefit Medicare Rebates/Medicare Part D Medicare Coverage Debt Ceiling and Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation H.R. 452, Medicare Decision Accountability Act, 2011 S. 1206, Medicare Drug Savings Act
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
2011 · second_quarter · 2A
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance Senate Labor - HHS Appropriations bill, with regard to funding of the 317 Program H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act
Medicare Prescription Drug Benefit Medicare Rebates Medicare Coverage Medicare Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation Debt Ceiling and Part D H.R. 452, Medicare Decision Accountability Act, 2011 S. 1206, Medicare Drug savings Act
2011 · fourth_quarter · Q4
Trans Pacific Partnership Negotiations
Medicare Rebates/Medicare Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders FDA Funding Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) Vaccines (317 Program appropriations, Immunization Improvements Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 1599, FY 2012 Labor HHS Appropriations Bill S. 668, Health Care Bureacrats Elimination Act, 2011
2011 · third_quarter · Q3
Trans Pacific Partnership Negotiations Japan Market Access and Regulatory Issues US-Korea Free Trade Agreement Israel Patent Issues Brazil IP - WTO Case Australian FTA Implementation Chile IP Issues - FTA Implementation
Medicare Prescription Drug Benefit Medicare Rebates/Medicare Part D Medicare Coverage Debt Ceiling and Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation H.R. 452, Medicare Decision Accountability Act, 2011 S. 1206, Medicare Drug Savings Act
Counterfeit Pharmaceuticals Patent Settlements Patent Reform Act, 2011 Protecting Consumer Access to Generic Drugs S. 27, Preserve Access to Affordable Generics S.23, America Invents Act, 2011 H.R. 1249, America Invents Act, 2011
2011 · second_quarter · Q2
Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance Senate Labor - HHS Appropriations bill, with regard to funding of the 317 Program H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act
Counterfeit Pharmaceuticals Expert Patent Courts Pilot Programs Patent Settlements Patent Reform Act, 2011 Protecting Consumer Access to Generic Drugs S. 27, Preserve Access to Affordable Generics S.23, America Invents Act, 2011 H.R. 1249, America Invents Act, 2011
2010 · fourth_quarter · Q4
Importation H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09 H.R. 573 - Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09
Medicare Prescription Drug Benefit Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation
Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
2010 · third_quarter · Q3
Medicare Prescription Drug Benefit Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation
Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
2010 · second_quarter · Q2
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act
2010 · first_quarter · Q1
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010
2009 · fourth_quarter · 4A
Wyeth Acquisition
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act S. 717 - 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H. Con Res 85 - Budget Reconciliation H.R. 2366 Cancer Drug Coverage Parity Act 0f 2009 H.R. 1548 - The Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 2366 - Cancer Drug Coverage parity Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act Health Information Technology Comparative Effectiveness Research Health Care Reform Proposals Follow on Biologics Medicare Part D
2009 · fourth_quarter · Q4
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 767 - Independent Drug Education and Outreach Act, 4/09 S. 882 - Drug and Device Accountability Act H.R. 163 - The Prescription Drug Affordability Act, 1/09 H.R. 91 - Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1256 - Family Smoking Prevention: Tobacco Control Act H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Wyeth Acquisition
2009 · fourth_quarter · Q4
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 767 - Independent Drug Education and Outreach Act, 4/09 S. 882 - Drug and Device Accountability Act H.R. 163 - The Prescription Drug Affordability Act, 1/09 H.R. 91 - Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1256 - Family Smoking Prevention: Tobacco Control Act H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act S. 717 - 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H. Con Res 85 - Budget Reconciliation H.R. 2366 Cancer Drug Coverage Parity Act 0f 2009 H.R. 1548 - The Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 2366 - Cancer Drug Coverage parity Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act Health Information Technology Comparative Effectiveness Research Health Care Reform Proposals Follow on Biologics Medicare Part D
Comprehensive Corporate Tax Reform International Tax Reform OECD Profit Allocation Manufacturing Credits
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Drug Pricing Biosimilars Out-of-Pocket Costs Rebate Reform Vaccine Infrastructure Antimicrobial Resistance
TRIPS Waiver
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Comprehensive Corporate Tax Reform International Tax Reform OECD Profit Allocation Manufacturing Credits
NAFTA/USMCA Foreign Market Access issues (including IPR) International Supply Chain/Buy America
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
TRIPS Waiver
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Comprehensive Corporate Tax Reform International Tax Reform OECD Profit Allocation Manufacturing Credits
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Foreign Market Access Issues (including IPR) NAFTA/USMCA International Supply Chain/Buy America U.S.- U.K. Trade Negotiations U.S. - Kenya FTA
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements Price Transparency
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements Price Transparency
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018
Creates Act Transferable exclusivity
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Medicare Part D Coverage Gap
Comprehensive Corporate Tax Reform Tax Cuts and Jobs Act of 2017 (TCJA)
Drug Pricing Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, Treasury, Dept of, White House Office
2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018
Medicare Part D Coverage Gap
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Creates Act Transferable exclusivity
Medicare Part D Coverage Gap
2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Office of the Vice President of the United States, SENATE, Treasury, Dept of, White House Office
Prescription Drug Abuse
2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018 Omnibus Appropriations Act of 2018
Drug Pricing Biosimilars Reimbursement Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Prescription Drug Abuse
Medicare Part D Coverage Gap Biosimilar pass-through
2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018 Omnibus Appropriations Act of 2018
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Creates Act Patent Settlements Transferable exclusivity
Drug Pricing Biosimilars Reimbursement Antibiotic Resistance/incentives Drug Shortages Reimbursement for products treating Sickle Cell Disease PAHPA
Prescription Drug Abuse
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
2018 FDA & Labor/HHS Appropriation Bills Bipartisan Budget Act of 2018 Omnibus Appropriations Act of 2018
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Office of the Vice President of the United States, Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Healthcare and access issues/IP Protection/Trade
Healthcare and access issues/IP Protection/Trade
Healthcare and access issues/IP Protection/Trade
Medicare Part D Medicare Part B CMMI Demo Medicare Part B Reimbursement Non-Interference Importation
Drug Pricing Biosimilars Reimbursement Antibiotic Resistance Drug Shortages Reimbursement for products treating Sickle Cell Disease
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Comprehensive Tax Reform Territorial Systems Deferral Border Adjustable Tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Drug Pricing User Fees Biosimilars Reimbursement Antibiotic Resistance
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Medicare Rebates/Medicare Part D Medicare Part B CMMI Demo Non-Interference Re-Importation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Canada IP/Trade Issues South Africa IP Issues China IP Issues Indonesia IP Issues Thailand IP Issues Korea Pricing Issues Saudia Arabia Pricing Issues United Nations Health Panel Privacy Shield G7/G20 APEC OECD
Deferral Comprehensive Tax Reform Territorial Systems Patent Innovation Box Inversions Section 385 Proposed Regulations Border Adjustable Tax
Prescription Drug Abuse
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Deferral Comprehensive Tax Reform Territorial Systems Patent Innovation Box Inversions Section 385 Proposed Regulations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Canada IP/Trade Issues South Africa IP Issues China IP Saudia Arabia Pricing Issues United Nations Health Panel Thermacare EU Privacy Shield G7/G20 APEC OECD
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Deferral Comprehensive Tax Reform Territorial Systems Patent Innovation Box Inversions Section 385 Proposed Regulations Border Adjustable Tax
Omnibus Appropriations Bill 2017 FDA & Labor/HHS Appropriation Bills
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy User Fees
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Omnibus Appropriations Bill LHHA Appropriations 2017 FDA & Labor/HHS Appropriation Bills
Deferral Comprehensive Tax Reform Territorial Systems Patent Innovation Box Cadillac Tax Inversions Section 385 Proposed Regulations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Prescription Drug Abuse
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Deferral Comprehensive Tax Reform Territorial Systems Patent Innovation Box Cadillac Tax Inversions Section 385 Proposed Regulations
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Canada IP/Trade Issues South Africa IP Issues China IP Saudia Arabia Pricing Issues United Nations Health Panel Thermacare EU Privacy Shield G7/G20 APEC OECD
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
21st Century Cures Initiative Senate Innovation Project Drug Pricing Biosimilars Reimbursement Policy
Patent Troll Legislation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Deferral Comprehensive Tax Reform Territorial Systems Tax Extenders Patent Innovation Box Cadillac Tax
Patent Troll Legislation
STOPPAct (Stop the Tampering of Prescription Pills)
Trans Pacific Partnership Negotiations Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues China IP Saudia Arabia Pricing Issues WTO Trade Facilitation Agreement (TFA) Trade Adjustment Assistance
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
FDA Funding HHS Appropriations 340B Antibiotics Dormant Therapies FDA Breakthrough Therapies 21st Century Cures Initiative Senate Innovation Project
Patent Troll Legislation
Preventing Abuse of Cough Treatment Act
STOPPAct (Stop the Tampering of Prescription Pills)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Medicare Rebates/Medicare Part D Non-Interference SGR "Fix" Negotiations IPAB
Deferral Comprehensive Tax Reform Territorial Systems Tax Extenders Patent Innovation Box
Preventing Abuse of Cough Treatment Act
STOPPAct (Stop the Tampering of Prescription Pills)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
STOPPAct (Stop the Tampering of Prescription Pills)
Patent Troll Legislation
Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues China IP Algeria Pricing Issues Venezuela Pricing Issues WTO Trade Facilitation Agreement (TFA) APEC Leaders Meeting Vietnam Distribution Israel Pricing
FDA Funding HHS Appropriations 340B Antibiotics Dormant Therapies FDA Breakthrough Therapies 21st Century Cures Initiative
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Health Care Reform FDA Funding Prescription Drug User Fee Act (PDUFA) Implementation HHS AppropriationsInterior Appropriations 340B
Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP)Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues Korea IP/Trade Issues China IP Saudia Arabia IP Turkey Pricing/IP Taiwan Pricing Issues Thailand Pricing Issues Egypt Pricing Issues Algeria Pricing Issues Venezuela Pricing Issues
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference SGR "Fix" Negotiations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Patent Troll Legislation
Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP) Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues China IP Saudia Arabia IP Taiwan Pricing Issues Algeria Pricing Issues Venezuela Pricing Issues WTO Trade Facilitation Agreement (TFA) APEC Leaders Meeting
Designer Anabolic Steroid Act Preventing Abuse of Cough Treatment Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Patent Settlements Patent Troll Legislation Preventing Abuse of Cough Treatment Act
Health Care Reform FDA Funding Prescription Drug User Fee Act (PDUFA) Implementation HHS AppropriationsInterior Appropriations 340B
Designer Anabolic Steroid Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Health Care Reform FDA Funding Prescription Drug User Fee Act (PDUFA) Implementation HHS AppropriationsInterior Appropriations
Patent Settlements Patent Troll Legislation CMS Rule Preventing Abuse of Cough Treatment Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference SGR "Fix" Negotiations
Trans Pacific Partnership Negotiations India IP/Trade Issues Miscellaneous Tariff Bill (MTB) Trans-Atlantic Trade & Investment Partnership (TTIP)Trade Promotion Authority/Fast-Track (TPA) Canada IP/Trade Issues South Africa IP Issues Korea IP/Trade Issues China IP Saudia Arabia IP Thailand Pricing Taiwan Pricing Turkey Pricing/IP
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Opioid Abuse Prescription Drug Abuse
Health Care Reform FDA Funding Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act)Prescription Drug User Fee Act (PDUFA) Implementation Sequester of User Fee Vaccines
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Deferral Excess Returns/Base Erosion Comprehensive Tax Reform Transition Rules for Comprehensive ReformTerritorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
Certified Importer Program Supply Chain Issues
Health Care Reform FDA Funding Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act)Prescription Drug User Fee Act (PDUFA) Implementation Sequester of User Fee Vaccines
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Trans Pacific Partnership Negotiations India Trade issues
Certified Importer Program Supply Chain Issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Health care implementation Patent protection Consumer health issues
Health care implementation Patent protection Consumer health issues
Health care implementation Patent protection Consumer health issues
Opioid Abuse Prescription Drug Abuse
Certified Importer Program Supply Chain Issues
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Certified Importer Program Supply Chain Issues
Health Care Reform FDA Funding Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act)Prescription Drug User Fee Act (PDUFA) Implementation Sequester of User Fee Vaccines
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR)
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation Non- Interference
Trans Pacific Partnership Negotiations India IP/Trade Issues
Patent Settlements Patent Reform Patent Troll Legislation
Certified Importer Program Supply Chain Issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Opioid Abuse Prescription Drug Abuse
Certified Importer Program Supply Chain Issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Trans Pacific Partnership Negotiations India Trade issues
Health Care Reform FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer ProgramDeficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Health Care Reform FDA Funding Drug Shortages Homeland Security and Agriculture Appropriations Bill on Certified Importer ProgramDeficit Reduction/Joint Select Committee Issues (Budget Control Act) S. 3817, Food and Drug Administration Safety and Innovation Act
Trans Pacific Partnership Negotiations India Trade issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Trans Pacific Partnership Negotiations
Opioid Abuse Prescription Drug Abuse
Deferral Tax Extenders Excess Returns/Base Erosion Comprehensive Tax Reform Territorial Systems Patent/Innovation Box Previously Taxed Income (PTI) Under Section 1248 H.R. 2735, CFC Look Through Permanency H.R. 2495, Tax Equity and Middle Class Fairness Act (excess returns) H.R. 4348, Authorized Surface Transportation Funding Through September 2014 and Extend Student Loan Rate for the Year S. 1813, Moving Ahead for Progress in the 21st Century Act "Highway Bill"
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Opioid Abuse Prescription Drug Abuse
Counterfeit Pharmaceuticals Patent Settlements Stop Online Piracy Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Counterfeit Pharmaceuticals Patent Settlements Stop Online Piracy Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Medicare Rebates/Medicare Part D Patient Protection and Affordable Care Act Implementation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Counterfeit Pharmaceuticals Patent Settlements Stop Online Piracy Act
Trans Pacific Partnership Negotiations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Counterfeit Pharmaceuticals Patent Settlements Patent Reform Act, 2011 Protecting Consumer Access to Generic Drugs S. 27, Preserve Access to Affordable Generics S.23, America Invents Act, 2011 H.R. 1249, America Invents Act, 2011
Trans Pacific Partnership Negotiations Japan Market Access and Regulatory Issues US-Korea Free Trade Agreement Israel Patent Issues Brazil IP - WTO Case Australian FTA Implementation Chile IP Issues - FTA Implementation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Counterfeit Pharmaceuticals Expert Patent Courts Pilot Programs Patent Settlements Patent Reform Act, 2011 Protecting Consumer Access to Generic Drugs S. 27, Preserve Access to Affordable Generics S.23, America Invents Act, 2011 H.R. 1249, America Invents Act, 2011
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Counterfeit Pharmaceuticals Patent Settlements Stop Online Piracy Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Health Care Reform Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Homeland Security and Agriculture Appropriations Bill on Certified Importer Program Deficit Reduction/Joint Select Committee Issues (Budget Control Act) H.R. 965, The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979, FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452, Medicare Decisions Accountability Act S. 668, Health Care Bureacrats Elimination Act, 2011 S. 1094, Combating Autism Act S. 1599, FY 2012 Labor HHS Appropriations Bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Medicare Prescription Drug Benefit Medicare Rebates Medicare Coverage Medicare Part D Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation Debt Ceiling and Part D H.R. 452, Medicare Decision Accountability Act, 2011 S. 1206, Medicare Drug savings Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Importation H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09 H.R. 573 - Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 767 - Independent Drug Education and Outreach Act, 4/09 S. 882 - Drug and Device Accountability Act H.R. 163 - The Prescription Drug Affordability Act, 1/09 H.R. 91 - Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1256 - Family Smoking Prevention: Tobacco Control Act H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act S. 717 - 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H. Con Res 85 - Budget Reconciliation H.R. 2366 Cancer Drug Coverage Parity Act 0f 2009 H.R. 1548 - The Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 2366 - Cancer Drug Coverage parity Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act Health Information Technology Comparative Effectiveness Research Health Care Reform Proposals Follow on Biologics Medicare Part D
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)
Wyeth Acquisition
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, Veterans Affairs, Dept of (VA)